Marimed (MRMD) Return on Capital Employed (2012 - 2026)

Marimed (MRMD) has 15 years of Return on Capital Employed data on file, last reported at 1.2% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 1.2%, down 115.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.2% (down 115.0% YoY), and the FY2025 annual result was 1.94%, down 366.0% from the prior year.
• Return on Capital Employed improved to 1.2% in Q1 2026 per MRMD's latest filing, from 1.86% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 28.02% in Q1 2022 and troughed at 1.86% in Q4 2025.
• A 5-year average of 8.01% and a median of 6.9% in 2024 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2022 and 2026: Return on Capital Employed tumbled 2190 bps in 2022, then sank 115 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 16.7% in 2022, then sank by 47 bps to 8.85% in 2023, then sank by 80 bps to 1.79% in 2024, then slumped by 204 bps to 1.86% in 2025, then jumped by 35 bps to 1.2% in 2026.
• Business Quant data shows MRMD's Return on Capital Employed at 1.2% in Q1 2026, 1.86% in Q4 2025, and 0.24% in Q3 2025.